Neurology
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • au-duo-banner-home
      Duodopa banner
      Duodopa
      Clinical Profile
      Duodopa Treatment
      Patient Cases
      Expert Insights
      Resources
      Training & e-Learning

      About Duodopa

      Duodopa is indicated for the treatment of advanced idiopathic Parkinson’s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.

      Long-term administration of Duodopa is via a permanent, but reversible, percutaneous endoscopic gastrostomy with jejunal extension (PEG-J) tube.

      A portable, programmable pump delivers the Duodopa gel directly to the duodenum or upper jejunum.1

      Resources guide for hospitals

      Case submitted
      by Dr Raju George

      69-year-old male patient

      presenting with progressing PD. The patient’s ON-time and OFF-time had narrowed to 1 hour and he was taking levodopa/benserazide 5 times a day. His movement was severely restricted and required the use of a walking stick.

      READ MORE

      Featured training modules

      Identifying Advanced Parkinson's disease

      Identifying Advanced Parkinson’s disease (aPD)

      Learn about aPD and be introduced to device-assisted therapies (DATs) as a treatment option.

      START LEARNING
      The patient journey with Duodopa

      The Patient Journey with Duodopa

      Learn what patients can expect from the Duodopa process and the outcome of the treatment.

      START LEARNING
      Contact a representative
      Contact a representative

      PBS Information

      DUODOPA: Authority required (STREAMLINED): S100 HSD Public, S100 HSD Private and S85 General Schedule. Refer to Pharmaceutical Benefits Scheme for full authority information.

      Please review the full Product Information (PI) before prescribing, available below.

      DUODOPA PI

      Abbreviation: CI, confidence interval; PD, Parkinson’s disease; PEG-J, percutaneous endoscopic gastrostomy with jejunal extension.
      References: 1. Duodopa Australian Product Information. 2. Olanow CW et al. Lancet Neurol 2014;13(2):141–149.

      AU-DUOD-230119. June 2024.